Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Exercise/Conversion of 50,000 PBYI shares, $146.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Exercise/Conversion | 50,000 | $146.5K |
| Jun 16, 2026 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/Award | 27,000 | n/a |
| Jan 13, 2026 | Zymeworks Inc. (ZYME) | Grant/Award | 11,500 | n/a |
| Jan 6, 2026 | Summit Therapeutics Inc. (SMMT) | Grant/Award | 35,000 | n/a |
| Jul 22, 2025 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale | 27,000 | $90.9K |
| Jun 17, 2025 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale | 12,150 | $41.3K |
| Jun 13, 2025 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/Award | 27,000 | n/a |
| Jan 7, 2025 | Summit Therapeutics Inc. (SMMT) | Grant/Award | 35,000 | n/a |
| Dec 12, 2024 | Zymeworks Inc. (ZYME) | Grant/Award | 31,000 | n/a |
| Jun 21, 2024 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/Award | 27,000 | n/a |